Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

Erstveröffentlichung
2019Authors
Reilmann, Ralf
McGarry, Andrew
Grachev, Igor D.
Savola, Juha-Matti
Borowsky, Beth
Wissenschaftlicher Artikel
Published in
Lancet Neurology ; 18 (2019), 2. - S. 165-176. - ISSN 1474-4422. - eISSN 1474-4465